Wealthfront’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
FMI
MWNA
Wealthfront's DGX Position: Q3 2018 in Review
Wealthfront reduced its Quest Diagnostics (DGX) stake by 5.6% in Q3 2018, selling an estimated $19.4K and leaving 2,965 shares worth $320K. The position accounts for ﹤0.01% of the portfolio, ranked #436.
Wealthfront first reported a position in DGX in Q1 2014 and has held it in 17 quarters since. The position peaked at $401K in Q2 2017. 674 funds tracked by Wall St. Rank hold DGX as of Q3 2018.
- Wealthfront held 2,965 shares of Quest Diagnostics worth $320K as of Q3 2018.
- Wealthfront sold 177 Quest Diagnostics shares in Q3 2018, an estimated $19.4K.
- Quest Diagnostics made up ﹤0.01% of Wealthfront's portfolio in Q3 2018, its #436 holding.
- Wealthfront first reported a position in Quest Diagnostics in Q1 2014 and has held it in 17 quarters since.
- Wealthfront's Quest Diagnostics position peaked at $401K in Q2 2017.
- 674 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2018.
Based on Wealthfront's 13F filing for Q3 2018, filed 13 Nov 2018.